KATHERINE FLAHERTY: Open Payments
NPI 1649693441 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 25 payments from 10 companies in 2025. Trend: 2023 $196 · 2024 $299 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| Regeneron Healthcare Solutions, Inc. | 3 | $99 |
| ABBVIE INC. | 3 | $65 |
| UCB, Inc. | 2 | $55 |
| GENZYME CORPORATION | 2 | $54 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34 |
| Amgen Inc. | 2 | $32 |
| Galderma Laboratories, L.P. | 2 | $29 |
| Organon LLC | 2 | $28 |
| Janssen Biotech, Inc. | 1 | $25 |
Products named: DUPIXENT, COSENTYX, RINVOQ, Bimzelx, Winlevi, OTEZLA, AKLIEF, TREMFYA.
Industry payments across IL — which companies pay providers there.
